Google’s project to ‘cure death,’ Calico, announces $1.5 billion research center
See the original posting on The Verge
The Google-backed life-extension company, Calico, announced today that it was partnering with Chicago-based pharmaceutical giant AbbVie to develop and bring to market new drugs targeting diseases associated with old age. Each partner has committed to providing $250 million in funding with the option to each add another $500 million to the project. The money will be used to create a new research center in San Francisco, where Calico will hire a team of researchers to discover new drugs and guide early development. AbbVie will focus more on the clinical trials, late-stage development, and bringing promising new drugs to market.